Product Details
Azarga
Brinzolamide + Timolol Maleate1% + 0.5%
Ophthalmic Suspension
5-mL Pack
DIN/PIN/NPN
02331624
Manufacturer
Novartis Pharma Canada Inc.
Formulary Listing Date
2010-06-14
Unit Price
20.4000
Amount MOH Pays
20.4000
Coverage Status
Limited Use Product
ODB Formulary Therapeutic Classification
Therapeutic Note
NO
ATC Code
S01ED51
Interchangeable Products
NOLU Clinical Criteria
| LU Code | Auth. Period | Clinical Criteria |
|---|---|---|
| 310 | Indefinite | As second-line therapy for patients who do not have an adequate intraocular pressure lowering response to monotherapy with ophthalmic beta-blocking agents |
| 393 | Indefinite | For use as initial therapy in an urgent situation (e.g., patients with a high baseline intraocular pressure) where monotherapy is unlikely to be effective |